Allegro Diagnostics

Category Archives

Allegro Diagnostics to Present Clinical Trial Results of BronchoGen™ Genomic Test to Improve Diagnosis of Lung Cancer in Late-Breaking Abstract Session at CHEST 2012

-- Confirmatory AEGIS II Study Recently Completed Enrollment -- Maynard, MA, August 27, 2012. Allegro Diagnostics today announced that results from its Read more...

Allegro Diagnostics Completes Patient Enrollment in 1,320-Patient AEGIS II Study of BronchoGen™ Genomic Test for Improved Detection of Lung Cancer

-- Results from AEGIS II and 730-patient AEGIS I clinical trial to support commercial launch --  Maynard, Mass., July 24, 2012 – Allegro Diagnostics Read more...

Allegro Completes Enrollment in Trial of Lung Cancer Test

By Don Seiffert Allegro Diagnostics Corp. has completed enrollment in a 1,320- patient clinical trial to evaluate the diagnostic ability of its BronchoGen Read more...

Allegro Diagnostics to Present at 2012 BIO International Convention

Maynard, Mass., June 6, 2012 – Allegro Diagnostics today announced its participation in the BIO Business Forum at the BIO International Convention, being Read more...

Allegro Diagnostics Promotes Duncan Whitney, Ph.D, to Senior Vice President, Research, Development and Technical Operations

Maynard, Mass., February 13, 2012 – Allegro Diagnostics today announced that Duncan Whitney, Ph.D., has been promoted to Senior Vice President, Research, Read more...

Boston University Names Avrum Spira its Innovator of the Year

Boston University Names Avrum Spira its Innovator of the Year (Boston) – Boston University School of Medicine Associate Prof. Avrum Spira has won the Read more...

Allegro Diagnostics Names Michael D. Webb President and Chief Executive Officer

Allegro Diagnostics Names Michael D. Webb President and Chief Executive Officer  MAYNARD, Mass.--(BUSINESS WIRE)-- Allegro Diagnostics, Inc. announced Read more...

Allegro Diagnostics Closes on $5.4M Financing Proceeds to Support Commercialization of BronchoGen™ Genomic Test for Early Detection of Lung Cancer

Allegro Diagnostics Closes on $5.4M Financing Proceeds to Support Commercialization of BronchoGen™ Genomic Test for Early Detection of Lung Cancer  MAYNARD, Read more...

Allegro Diagnostics Enters License Agreement for Lung Cancer Molecular Testing Platform with Boston University and the University of Utah Foundation

Allegro Diagnostics Enters License Agreement for Lung Cancer Molecular Testing Platform with Boston University and the University of Utah Foundation MAYNARD, Read more...

Duncan Whitney, Ph.D. Joins Allegro Diagnostics as Vice President, Research & Development

Duncan Whitney, Ph.D. Joins Allegro Diagnostics as Vice President, Research & Development BOSTON, Apr. 15 /PRNewswire/ — Allegro Diagnostics, a leader Read more...

Page 2 of 3123

Contact Info

info@catalysthealthventures.com

(781) 228-5228

50 Braintree Hill Office Park
Suite 301
Braintree, MA 02184